Stock 600566 HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 26/06/2024 am IST 		5-day change 1st Jan Change
33 CNY +1.60% Intraday chart for Hubei Jumpcan Pharmaceutical Co., Ltd. -1.79% +5.00%
07:11am Hubei Jumpcan Pharmaceutical Obtains Drug Registration for Antibiotic Injection; Shares Down 3% MT
20/06 Hubei Jumpcan Pharmaceutical Gets Drug Registration Certificate for Allergy Drug; Shares Slide 3% MT

Business Summary

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.

Number of employees: 5,230

Sales per Business

CNY in Million2022Weight2023Weight Delta
Traditional Chinese Medicine
76.1 %
6,474 72.0 % 7,348 76.1 % +13.49%
Western Medicine
21.8 %
2,323 25.8 % 2,107 21.8 % -9.29%
Others
1.9 %
180 2.0 % 184 1.9 % +2.05%
Other Business
0.2 %
20 0.2 % 17 0.2 % -16.90%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
8,996 100.0 % 9,655 100.0 % +7.32%

Managers

Managers TitleAgeSince
Fei Cao CEO
 Chief Executive Officer 41 10/14/10
Hong Cun Yan DFI
 Director of Finance/CFO 56 10/14/10
Long Xiang Cao CHM
 Chairman 67 10/14/10
Wei Cao BRD
 Director/Board Member 38 17/18/17
Qu Rong Huang BRD
 Director/Board Member 62 10/14/10

Members of the board

Members of the board TitleAgeSince
Long Xiang Cao CHM
 Chairman 67 10/14/10
Qu Rong Huang BRD
 Director/Board Member 62 10/14/10
Fei Cao CEO
 Chief Executive Officer 41 10/14/10
Chao Jun Lu BRD
 Director/Board Member 54 02/20/02
Xin Chun Zhou CHM
 Chairman 55 19/19/19
Hong Yao BRD
 Director/Board Member 50 02/20/02
Wei Cao BRD
 Director/Board Member 38 17/18/17
Yu Hai Yang BRD
 Director/Board Member 55 25/22/25
Yong Chun Ding BRD
 Director/Board Member 48 08/23/08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 921,806,660 329,904,961 ( 35.79 %) 6,790,000 ( 0.7366 %) 35.79 %

Shareholders

NameEquities%Valuation
Long Xiang Cao
61.54 %
563,595,818 61.54 % 2 963 M ¥
HuaAn Fund Management Co., Ltd.
0.9988 %
9,146,163 0.9988 % 48 M ¥
Hong Yu Ge
0.7451 %
6,823,200 0.7451 % 36 M ¥
Jingzhou State-Owned Asset Management Committee
0.7392 %
6,768,802 0.7392 % 36 M ¥
GF Fund Management Co., Ltd.
0.6073 %
5,561,642 0.6073 % 29 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.5814 %
5,324,066 0.5814 % 28 M ¥
Bu Song Liu
0.4993 %
4,572,683 0.4993 % 24 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.4673 %
4,279,500 0.4673 % 23 M ¥
Guang Zhi Shi
0.4499 %
4,119,900 0.4499 % 22 M ¥
China Southern Asset Management Co., Ltd.
0.4310 %
3,946,747 0.4310 % 21 M ¥

Company contact information

Hubei Jumpcan Pharmaceutical Co., Ltd.

Baota Bay Daqing West Road

225441, Taizhou

+86 71 6812 4260

http://www.jumpcan.com
address Hubei Jumpcan Pharmaceutical Co., Ltd.(600566)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Ratings for Hubei Jumpcan Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
33 CNY
Average target price
52.36 CNY
Spread / Average Target
+58.67%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. Stock Hubei Jumpcan Pharmaceutical Co., Ltd.
+5.00% 4.19B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.19% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.85% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.39% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 333B
ABBVIE INC. Stock AbbVie Inc.
+9.65% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.38% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.45% 225B
NOVARTIS AG Stock Novartis AG
+12.82% 218B
AMGEN INC. Stock Amgen Inc.
+9.09% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600566 Stock
  4. Company Hubei Jumpcan Pharmaceutical Co., Ltd.